177 related articles for article (PubMed ID: 23533487)
1. QiShenYiQi Pills, a Compound Chinese Medicine, Ameliorates Doxorubicin-Induced Myocardial Structure Damage and Cardiac Dysfunction in Rats.
Tang DX; Zhao HP; Pan CS; Liu YY; Wei XH; Yang XY; Chen YY; Fan JY; Wang CS; Han JY; Li PP
Evid Based Complement Alternat Med; 2013; 2013():480597. PubMed ID: 23533487
[TBL] [Abstract][Full Text] [Related]
2. Attenuating effect of post-treatment with QiShen YiQi Pills on myocardial fibrosis in rat cardiac hypertrophy.
Li YC; Liu YY; Hu BH; Chang X; Fan JY; Sun K; Wei XH; Pan CS; Huang P; Chen YY; Wang CS; Zheng J; Han JY
Clin Hemorheol Microcirc; 2012; 51(3):177-91. PubMed ID: 22240383
[TBL] [Abstract][Full Text] [Related]
3. QiShenYiQi Pills® prevent cardiac ischemia-reperfusion injury via energy modulation.
Lin SQ; Wei XH; Huang P; Liu YY; Zhao N; Li Q; Pan CS; Hu BH; Chang X; Fan JY; Yang XY; Wang CS; Liu HN; Han JY
Int J Cardiol; 2013 Sep; 168(2):967-74. PubMed ID: 23168012
[TBL] [Abstract][Full Text] [Related]
4. A novel traditional Chinese medicine ameliorates fatigue-induced cardiac hypertrophy and dysfunction via regulation of energy metabolism.
Huang R; Cui YC; Wei XH; Pan CS; Li Q; He SY; Fan JY; Han JY
Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1378-H1388. PubMed ID: 30951366
[TBL] [Abstract][Full Text] [Related]
5. QiShenYiQi Pills
Zheng QN; Wei XH; Pan CS; Li Q; Liu YY; Fan JY; Han JY
Pharmacol Res; 2019 Aug; 146():104272. PubMed ID: 31085230
[TBL] [Abstract][Full Text] [Related]
6. QiShenYiQi dripping pill alleviates myocardial ischemia-induced ferroptosis via improving mitochondrial dynamical homeostasis and biogenesis.
Wu L; Fan Z; Gu L; Liu J; Cui Z; Yu B; Kou J; Li F
J Ethnopharmacol; 2023 May; 308():116282. PubMed ID: 36806343
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective Effects of QiShenYiQi Dripping Pills on Transverse Aortic Constriction-Induced Heart Failure in Mice.
Ruan G; Ren H; Zhang C; Zhu X; Xu C; Wang L
Front Physiol; 2018; 9():324. PubMed ID: 29666587
[TBL] [Abstract][Full Text] [Related]
8. QiShenYiQi pill for myocardial collagen metabolism and apoptosis in rats of autoimmune cardiomyopathy.
Lv S; Zhang W; Yuan P; Lu C; Dong J; Zhang J
Pharm Biol; 2022 Dec; 60(1):722-728. PubMed ID: 35361037
[TBL] [Abstract][Full Text] [Related]
9. Lingguizhugan decoction attenuates doxorubicin-induced heart failure in rats by improving TT-SR microstructural remodeling.
Li X; Xu G; Wei S; Zhang B; Yao H; Chen Y; Liu W; Wang B; Zhao J; Gao Y
BMC Complement Altern Med; 2019 Dec; 19(1):360. PubMed ID: 31829159
[TBL] [Abstract][Full Text] [Related]
10. The Contribution of Different Components in QiShenYiQi Pills® to Its Potential to Modulate Energy Metabolism in Protection of Ischemic Myocardial Injury.
Cui YC; Yan L; Pan CS; Hu BH; Chang X; Fan JY; Han JY
Front Physiol; 2018; 9():389. PubMed ID: 29755361
[TBL] [Abstract][Full Text] [Related]
11. QiShenYiQi Pills Attenuates Ischemia/Reperfusion-Induced Cardiac Microvascular Hyperpermeability Implicating Src/Caveolin-1 and RhoA/ROCK/MLC Signaling.
Pan CS; Yan L; Lin SQ; He K; Cui YC; Liu YY; Hu BH; Chang X; Zhao XR; Fan JY; Han JY
Front Physiol; 2021; 12():753761. PubMed ID: 34975519
[No Abstract] [Full Text] [Related]
12. An integrated evidence-based targeting strategy for determining combinatorial bioactive ingredients of a compound herbal medicine Qishen Yiqi dripping pills.
Zhang Y; Yu J; Zhang W; Wang Y; He Y; Zhou S; Fan G; Yang H; Zhu Y; Li P
J Ethnopharmacol; 2018 Jun; 219():288-298. PubMed ID: 29572106
[TBL] [Abstract][Full Text] [Related]
13. [Change of short-chain acyl-CoA dehydrogenase in heart failure after myocardial infarction in rats and the intervention of aerobic exercise].
Liao Y; Li Z; Shu Z; Zhong X; Su Y; Ma Z; Liu P; Lu J; Zang L; Pan X; Zhou S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Feb; 31(2):172-177. PubMed ID: 30827304
[TBL] [Abstract][Full Text] [Related]
14. Multi-omics approach for identification of molecular alterations of QiShenYiQi dripping pills in heart failure with preserved ejection fraction.
Huang Y; Zhang K; Wang X; Guo K; Li X; Chen F; Du R; Li S; Li L; Yang Z; Zhuo D; Wang B; Wang W; Hu Y; Jiang M; Fan G
J Ethnopharmacol; 2023 Oct; 315():116673. PubMed ID: 37268257
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotection against ischemia/reperfusion injury by QiShenYiQi Pill® via ameliorate of multiple mitochondrial dysfunctions.
Chen JR; Wei J; Wang LY; Zhu Y; Li L; Olunga MA; Gao XM; Fan GW
Drug Des Devel Ther; 2015; 9():3051-66. PubMed ID: 26109848
[TBL] [Abstract][Full Text] [Related]
16. QiShenYiQi pills, a Chinese patent medicine, increase bioavailability of atorvastatin by inhibiting Mrp2 expression in rats.
Ding C; Li Y; Li X; Meng L; Fu R; Wang X; Li Y; Ma Y; Dong Z
Pharm Biol; 2022 Dec; 60(1):185-194. PubMed ID: 35001796
[TBL] [Abstract][Full Text] [Related]
17. A critical courier role of volatile oils from Dalbergia odorifera for cardiac protection in vivo by QiShenYiQi.
Yu J; Zhang W; Zhang Y; Wang Y; Zhang B; Fan G; Zhu Y
Sci Rep; 2017 Aug; 7(1):7353. PubMed ID: 28779167
[TBL] [Abstract][Full Text] [Related]
18. Multipronged Therapeutic Effects of Chinese Herbal Medicine Qishenyiqi in the Treatment of Acute Myocardial Infarction.
Wang Y; Lin W; Li C; Singhal S; Jain G; Zhu L; Lu L; Zhu R; Wang W
Front Pharmacol; 2017; 8():98. PubMed ID: 28303103
[No Abstract] [Full Text] [Related]
19. Astragalus polysaccharide attenuates isoproterenol-induced cardiac hypertrophy by regulating TNF-α/PGC-1α signaling mediated energy biosynthesis.
Luan A; Tang F; Yang Y; Lu M; Wang H; Zhang Y
Environ Toxicol Pharmacol; 2015 May; 39(3):1081-90. PubMed ID: 25880160
[TBL] [Abstract][Full Text] [Related]
20. A network pharmacology study of Chinese medicine QiShenYiQi to reveal its underlying multi-compound, multi-target, multi-pathway mode of action.
Li X; Wu L; Liu W; Jin Y; Chen Q; Wang L; Fan X; Li Z; Cheng Y
PLoS One; 2014; 9(5):e95004. PubMed ID: 24817581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
